Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma ; volume:10 ; number:1 ; day:18 ; month:6 ; year:2018 ; pages:1-11 ; date:12.2018
Clinical epigenetics ; 10, Heft 1 (18.6.2018), 1-11, 12.2018
- Urheber
-
Bensaid, Douae
- Beteiligte Personen und Organisationen
-
Blondy, Thibaut
Deshayes, Sophie
Dehame, Virginie
Bertrand, Philippe
Grégoire, Marc
Errami, Mohammed
Blanquart, Christophe
SpringerLink (Online service)
- DOI
-
10.1186/s13148-018-0517-9
- URN
-
urn:nbn:de:101:1-2018082822525531314922
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bensaid, Douae
- Blondy, Thibaut
- Deshayes, Sophie
- Dehame, Virginie
- Bertrand, Philippe
- Grégoire, Marc
- Errami, Mohammed
- Blanquart, Christophe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Physician requests by patients with malignant pleural mesothelioma in Japan
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Physician requests by patients with malignant pleural mesothelioma in Japan
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma